Pharmacology

Anesthesia Drugs $7 Billion Market In U.S. By 2015

The 'Anesthesia Drugs Market (2011- 2015)- U.S. Market Entry Study' analyzes and studies the U.S. market for intravenous anesthesia drugs with special focus on ketamine, distribution structure of anesthesia drugs in U.S., potential buyers, expor ...

Article - Newswire - May 20 2012 - 5:09pm

Viagra- Now For Kids!

A double-blind, placebo-controlled, crossover trial of sildenafil, brand name Viagra, showed improvement in echocardiogram measures of myocardial performance in children and young adults after Fontan surgery- basically, kids with congenital heart defects w ...

Blog Post - Hank Campbell - May 17 2012 - 4:06pm

Zebinix Once-Daily Epilepsy Treatment Now Available In Sweden

Reimbursement granted for Zebinix (eslicarbazepine acetate) as adjunctive therapy for adults with partial-onset seizures   Eisai Europe Limited has announced the launch of Zebinix which will receive full reimbursement from Swedish health authorities.   On ...

Article - Newswire - May 27 2012 - 9:00am

Promising Phase II Data For Tiotropium In Adolescent Asthma Patients

A Phase II study presented today at the 2012 Annual Meeting of the American Thoracic Society showed positive results for once-daily tiotropium via the Respimat(R) Soft Mist(TM) Inhaler (SMI) device in adolescents with symptomatic, moderate, persistent ast ...

Article - Newswire - May 26 2012 - 9:00am

Data From Brentuximab Vedotin (SGN-35) Pivotal Phase II Trial

Results from a pivotal phase II trial of brentuximab vedotin, published in the Journal of Clinical Oncology, showed that 86% of patients with relapsed or refractory systemic anaplastic large cell lymphoma (sALCL),[1] achieved the primary endpoint of objec ...

Article - Newswire - May 23 2012 - 6:36pm

Positive Phase 2 Results For Lipid-Lowering PCSK9 Antibody

 Sanofi and Regeneron Pharmaceuticals, Inc. today announced additional positive results from a Phase 2 trial of SAR236553/REGN727 (Study 1003, NTC01266876) in patients with heterozygous familial hypercholesterolemia (heFH). SAR236553/REGN727 is a subcutan ...

Article - Newswire - May 26 2012 - 11:39pm

Positive CHMP Opinion For Perampanel In Focal Epilepsy

Eisai announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for the use of Fycompa(R) (perampanel) as an adjunctive treatment of focal seizures, with or without second ...

Article - Newswire - May 29 2012 - 2:30am

Antioxidants For Autism

A specific antioxidant supplement containing  N-Acetylcysteine, or NAC may be an effective therapy for some features of autism, according to a pilot trial from the Stanford University School of Medicine and Lucile Packard Children's Hospital that invo ...

Article - News Staff - May 30 2012 - 3:30pm

Positive Phase 2 Study Results For Tivantinib In Previously Treated Hepatocellular Carcinoma

ArQule, Inc. and Daiichi Sankyo Co., Ltd. today announced final results from a randomized, placebo-controlled, double-blind, phase 2 clinical trial with the selective MET inhibitor tivantinib as a single-agent, investigational, second-line treatment in he ...

Article - Newswire - Jun 2 2012 - 3:05pm

When Kids Need Meds: A Must Have For Parents Of Special Needs Kids

Parents of children with neurological conditions and disorders and mental health issues are often faced with the frightening and difficult decision of whether to medicate for specific issues and behaviors. Parents are already stressed, worried, and expecti ...

Article - Kim Wombles - Jun 5 2012 - 10:10am